$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
$NVAX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Novavax (NASDAQ:NVAX) has outperformed the market over the past 5 years by 15.36% on an annualized basis producing an average annual return of 29.01%. Currently, Novavax has a market capitalization of $2.42 billion.
Buying $100 In NVAX: If an investor had bought $100 of NVAX stock 5 years ago, it would be worth $356.62 today based on a price of $16.40 for NVAX at the time of writing.
Novavax's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.